Related Experiment Video
Updated: Dec 3, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Identification of key genes and pathways for melanoma in the TRIM family
YiJun Xia1, Jun Zhao2, Chunjun Yang2
1Department of Plastic and Reconstructive Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China.
Abstract:
Certain members of the TRIM family have been shown to have abnormal expression and prognostic value in cancer. However, in the development and progression of melanoma, the role of different TRIM family members remains unknown. To address this issue, this study used the Oncomine, UCSC, Human Protein Atlas, DAVID, and GEPIA databases to study the role of TRIMs in the prognosis of melanoma. Differential expression of TRIM2, TRIM7, TRIM8, TRIM18 (MID1), TRIM19 (PML), TRIM27, and TRIM29 may play an important role in the development of melanoma. The expression TRIM7 and TRIM29 appeared to be helpful in the identification of primary tumors and metastases. Survival analysis suggested that the expression of TRIM27 significantly affected the overall survival and disease-free survival of melanoma, and its expression was confirmed by qRT-PCR. Our results indicated that the expression level of TRIM27 might be a prognostic marker of melanoma.
Insights
This study investigated the role of TRIM family proteins in melanoma development. TRIM27 expression was found to be a significant prognostic marker for melanoma survival.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Members of the TRIM (Tripartite Motif) family exhibit altered expression and prognostic significance in various cancers.
- The specific roles of TRIM family members in melanoma development and progression are not well understood.
Purpose of the Study:
- To investigate the expression patterns and prognostic value of TRIM family members in melanoma.
- To identify potential TRIM-based biomarkers for melanoma diagnosis and prognosis.
Main Methods:
- Utilized bioinformatics databases including Oncomine, UCSC, Human Protein Atlas, DAVID, and GEPIA for expression analysis.
- Performed quantitative real-time PCR (qRT-PCR) for validation.
- Conducted survival analysis to assess the impact of TRIM expression on patient outcomes.
Main Results:
- Differential expression of TRIM2, TRIM7, TRIM8, TRIM18 (MID1), TRIM19 (PML), TRIM27, and TRIM29 was observed in melanoma.
- TRIM7 and TRIM29 expression may aid in distinguishing primary tumors from metastases.
- TRIM27 expression significantly correlated with overall survival and disease-free survival in melanoma patients.
Conclusions:
- TRIM family proteins, particularly TRIM27, play a crucial role in melanoma development and progression.
- TRIM27 expression level serves as a potential prognostic biomarker for melanoma.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Intrinsic Apoptotic Pathway

